Semaglutide works by triggering GLP-1 receptors in the brain, which reduces food intake and increases feelings of fullness
Aminosalicylates for induction of remission or response in crohns disease
Of note, GSTO1 was identified as one of the cellular targets of locostatin, an oxazolidinone-based cell migration inhibitor, although its role in cell migration has not been well characterized 42
It also blocks glucagon, a hormone that raises blood sugar, slows digestion to reduce sugar release into the bloodstream, and increases feelings of fullness after eating
The weight continued to increase due to lack of exercise and going to physical therapy multiple times a week due to previous injury
It is currently one of the most advanced candidates in the oral GLP-1 category